The prevention of hospital-acquired venous thromboembolism in the United Kingdom

British Journal of Haematology

Volumn 144, Issue 5, 2009, Pages 642-652

  Hunt, Beverley J ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Thromboprophylaxis; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; DABIGATRAN ETEXILATE; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RIVAROXABAN; WARFARIN; XIMELAGATRAN;

BLEEDING; CLINICAL TRIAL; COMPRESSION GARMENT; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG WITHDRAWAL; HOSPITALIZATION; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LIVER TOXICITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; GREAT BRITAIN; GUIDELINE ADHERENCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 58849092754     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07517.x     Document Type: Review

References (73)

1. Agnelli, G., Bergqvist, D., Cohen, A.T., Gallus, A.S., Gent, M. PEGASUS Investigators (2005) Randomised clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. British Journal of Surgery, 92, 1212 1220.
2. Agnelli, G., Eriksson, B.I., Cohen, A.T., Bergqvist, D., Dahl, O.E., Lassen, M.R., Mouret, P., Rosencher, N., Andersson, M., Bylock, A., Jensen, E. Boberg, B., on behalf of the EXTEND Study Group (2008) Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran. Thrombosis Research, doi :.
3. All Party Parliamentary Thrombosis Group (2007) Thrombosis awareness, assessment, management & prevention. An audit of acute hospital Trusts November 2007. Available at: http://www.thrombosis-charity.org.uk/cms/images/ stories/File/reports/DVT%20Report%202007.pdf.
4. Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomised control trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. British Medical Journal, 308, 235 246.
5. Baglin, T.P., Brush, J. Streiff, M. on behalf of the British Committee for Standards in Haematology Writing Group (2006) Guidelines on the use of vena cava filters. British Journal of Haematology, 134, 590 595.
6. Bates, S.M., Greer, I.A., Pabinger, I., Sofaer, S., Hirsh, J. American College of Chest Physicians (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest, 133, 844S 886S.
7. Beasley, R., Heuser, P. Raymond, N. (2005) SIT (seated immobility thromboembolism) syndrome: a 21st century lifestyle hazard. New Zealand Medical Journal, 118, U1376.
8. Bergqvist, D., Burmark, U.S., Frisell Hallböök, J.T., Lindblad, B., Risberg, B., Törngren, S. Wallin, G. (1986) Low molecular once daily compared with conventional compared with conventional low-dose heparin twice daily: a prospective double-blind multicentre trial on prevention of thrombosis. British Journal of Surgery, 73, 204 208.
9. Bergqvist, D., Matzch, T., Burmark Frisell, U.S.J., Guilbaud, O., Hallböök, T., Horn, A., Lindhagen, A., Ljungnér, H. Ljungström, K.G. (1988) Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. British Journal of Surgery, 75, 888 891.
10. Bergqvist, D., Agnelli, G., Cohen, A.T., Eldor, A., Nilsson, P.E., Le Moigne-Amrani, A., Dietrich-Neto, F. ENOXACAN II Investigators (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. New England Journal of Medicine, 346, 975 980.
11. Chopard, P., Dörffler-Melly, J., Hess, U., Wuillemin, W.A., Hayoz, D., Gallino, A., Bachli, E.B., Canova, C.R., Isenegger, J., Rubino, R. Bounameaux, H. (2005) Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. Journal of Internal Medicine, 257, 352 357.
12. Clagett, G.P. Reisch, J.S. (1988) Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Annals of Surgery, 208, 227 240.
13. Cohen, A.T., Davidson, B.L., Gallus, A.S., Lassen, M.R., Prins, M.H., Tomkowski, W., Turpie, A.G., Egberts, J.F., Lensing, A.W. ARTEMIS Investigators (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. British Medical Journal, 332, 325 329.
14. Cohen, A.T., Agnelli, G., Anderson, F.A., Arcelus, J.I., Bergqvist, D., Brecht, J.G., Greer, I.A., Heit, J.A., Hutchinson, J.L., Kakkar, A.K., Mottier, D., Oger, E., Samama, M.M. Spannagl, M. (2007a) l. Venous thromboembolism in Europe: the number of VTE events and associated morbidity and mortality. Thrombosis and Haemostasis, 98, 756 764.
15. Cohen, A.T., Skinner, J.A., Warwick, D. Brenkel, I. (2007b) The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, randomised, open-label, parallel-group comparative study. Journal of Bone and Joint Surgery, 89, 887 892.
16. Cohen, A.T., Tapson, V.F., Bergmann, J.F., Goldhaber, S.Z., Kakkar, A.K., Deslandes, B., Huang, W., Zayaruzny, M., Emery, L., Anderson, Jr., F.A. ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet, 371, 387 394.
17. Collins, R., Scrimgeour, A., Yusuf, S. Petro, R. (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomised trials in general, orthopaedic, and urological surgery with low doses of heparin. New England Journal of Medicine, 318, 1162 1173.
18. Cook, D., Attia, J., Weaver, B., McDonald, E., Meade, M. Crowther, M. (2000) Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. Journal of Critical Care, 15 (4 127 132.
19. Cook, D.J., Rocker, G., Meade, M., Guyatt, G., Geerts, W., Anderson, D., Skrobik, Y., Hebert, P., Albert, M., Cooper, J., Bates, S., Caco, C., Finfer, S., Fowler, R., Freitag, A., Granton, J., Jones, G., Langevin, S., Mehta, S., Pagliarello, G., Poirier, G., Rabbat, C., Schiff, D., Griffith, L., Crowther, M. PROTECT Investigators; Canadian Critical Care Trials Group (2005) Prophylaxis of thromboembolism in critical care (PROTECT) trial: a pilot study. Journal of Critical Care, 20, 364 372.
20. Cushman, M., Tsai, A.W., White, R.H., Heckbert, S.R., Rosamond, W.D., Enrights, P. Folsom, A.R. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts. The longitudinal investigation of thromboembolism: etiology. American Journal of Medicine, 117, 19 25.
21. Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F., Huet, Y. Simonneau, G. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. New England Journal of Medicine, 338, 409 415.
22. Dentali, F., Douketis, J.D., Gianni, M., Lim, W. Crowther, M.A. (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalised medical patients. Annals of Internal Medicine, 146, 278 288.
23. Donaldson, L. 2007) Recommendations of the expert working group on the prevention of venous thromboembolism in hospitalized patients. Available at: http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/documents/ digitalasset/dh-073958.pdf
24. Eriksson, B.I., Dahl, O.E., Rosencher, N., Kurth, A.A., van Dijk, C.N., Frostick, S.P., Prins, M.H., Hettiarachchi, R., Hantel, S., Schnee, J., Buller, H.R. RENOVATE Study Group (2007a) Dadigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet, 370, 949 956.
25. Eriksson, B.I., Dahl, O.E., Rosencher, N., Kurth, A.A., van Dijk, C.N., Frostick, S.P., Prins, M.H., Hettiarachchi, R., Hantel, S., Schnee, J., Buller, Hr. RE-MODEL Study Group (2007b) Oral dabigatran etexilate versus subcutaneous enoxaparin for prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomised. Journal of Thrombosis and Haemostasis, 5, 2178 2185.
26. Eriksson, B.I., Borris, L.C., Friedman, R.J., Haas, S., Huisman, M.V., Kakkar, A.K., Bandel, T.J., Beckmann, H., Muehlhofer, E., Misselwitz, F., Geerts, W. RECORD1 Study Group (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. New England Journal of Medicine, 358, 2765 2775.
27. Fisher, W.D., Eriksson, B.I., Bauer, K.A., Borris, L., Dahl, O.E., Gent, M., Haas, S., Homering, M., Huisman, M.V., Kakkar, A.K., Kalebo, P., Kwong, L.M., Misselwitz, F. Turpie, A.G. (2007) Rivaroxaban in thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thrombosis and Haemostasis, 97, 931 937.
28. Francis, C. (2007) Prophylaxis for thromboembolism in hospitalised medical patients. New England Journal of Medicine, 356, 1438 1444.
29. Geerts, W.H., Pineo, G.F., Heit, J.A., Bergqvist, D., Lassen, M.R., Cowell, C.W. Ray, J.G. (2004) Prevention of venous thomboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126 (Suppl. 3 338S 400S.
30. Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. Cowell, C.W. (2008) Prevention of venous thomboembolism: ACCP evidence based clinical practice guidelines. Chest, 133, 381S 453S.
31. Girard, T.D., Philbrick, J.T., Fritz Angle, J.F. Becker, D.M. (2003) Prophylactic vena caval filters for trauma patients: a systematic review of the literature. Thrombosis Research, 112, 261 267.
32. Graor, R.A., Stewart, J., Lotke, P.A. Davidson, P.C. (1992) Heparin vs aspirin to prevent deep venous thrombosis after hip or knee replacement surgery [abstract]. Chest, 102, 118S.
33. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., Lohse, C.M., O' Fallon, W.M. Melton, III., L.J. (2001) The epidemiology of venous thromboembolism in the community. Thrombosis and Haemostasis, 86, 452 463.
34. Heit, J.A., O' Fallon, W.M., Petterson, T.M., Lohse, C.M., Silverstein, M.D., Mohr, D.N. Melton, III., L.J. (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Archives of Internal Medicine, 162, 1245 1248.
35. Hitos, K., Cannon, M., Cannon, S., Garth, A., Fletcher, J.P. Beasley, R. (2007) Effect of leg exercises on popliteal blood flow during prolonged immobility of seated subjects: implication for prevention of travel-reated deep vein thrombosis. Journal of Thrombosis and Haemostasis, 5, 1890 1895.
36. House of Commons Health Select Committee (2005) Report on the prevention of venous thromboembolism in hospitalizes patients - second report of session 2004-5. Available at: http://www.publications.parliament.uk/pa/cm200405/ cmselect/cmhealth/99/99.pdf
37. Huber, O., Bounameaux, H., Borst, F. Rohner, A. (1992) Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Archives of Surgery, 127, 310 313.
38. Hull, R.D., Schellong, S.M., Tapson, V.F., Monreal, M., Samama, M.M., Turpie, A.G., Wildgoose, P. Yusen, R.D. (2006) Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. Journal of Thrombosis and Thrombolysis, 22, 31 38.
39. Kakkar, V.V., Corrigan, T.P., Fossard, D.P. Sutherland, I. (1975) Prevention of fatal pulmonary embolism and venous thrombosis by low doses of heparin. An international multicentre trial. Lancet, 2, 45 51.
40. Kakkar, A.K., Brenner, B., Dahl, O.E., Eriksson, B.I., Mouret, P., Muntz, J., Soglian, A.G., Pap, A.F., Misselwitz, F., Haas, S. RECORD2 Investigators (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet, 372, 31 39.
41. Kakkhar, V.V., Howe, C., Flane, C. Clarke, M.B. (1969) Natural history of post-operative deep vein thrombosis. Lancet, 2, 230 233.
42. Kelly, J., Rudd, A., Lewis, R.R., Coshall, C., Moody, A. Hunt, B.J. (2004) Venous thromboembolism after acute ischaemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke, 35, 2320 2325.
43. King, C.S., Holley, A.B., Jackson, J.L., Shorr, A.F. Moores, L.K. (2007) Twice vs thrice times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a metaanalysis. Chest, 131, 507 516.
44. Koch, A., Bouges, S., Ziegler, S., Dinkel, H., Daures, J.P. Victor, N. (1997) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta analyses. British Journal of Surgery, 84, 750 759.
45. Kucher, N., Koos, S., Quirez, R., Cooper, J.M., Paterno, M.D., Soukonnikov, B. Goldhaber, S.Z. (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. New England Journal of Medicine, 352, 969 977.
46. Lassen, M.R., Ageno, W., Borris, L.C., Lieberman, J.R., Rosencher, N., Bandel, T.J., Misselwitz, F., Turpie, A.G. RECORD3 Investigators (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. New England Journal of Medicine, 358, 2776 2786.
47. Leizorovicz A Cohen, A.T., Turpie, A.G., Olsson, C.G., Vaitkus, P.T. Goldhaber, S.Z. (2004) A randomised placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely ill medical patients: the PREVENT medical thromboprophylaxis study trial. Circulation, 110, 874 879.
48. McLeod, R.S., Geerts, W.H., Sniderman, K.W., Greenwood, C., Gregoire, R.C., Taylor, B.M., Silverman, R.E., Atkinson, K.G., Burnstein, M., Marshall, J.C., Burul, C.J., Anderson, D.R., Ross, T., Wilson, S.R., Barton, P. Canadian Colorectal Surgery DVT Prophylaxis Trial investigators (2001) Subcutaneous heparin versus low molecular weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomised double blind trial. Annals of Surgery, 233, 438 444.
49. Mismetti, P., Laporte, S., Darmon, J.Y., Buchmuller, A. Decousus, H. (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. British Journal of Surgery, 88, 913 930.
50. Muir, K.W., Watt, A., Baxter, G., Grosset, D.G. Lees, K.R. (2000) Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Quarterly Journal of Medicine, 93, 359 364.
51. NICE (2007). Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. ref CG46. Available at: http://www.nice.org.uk/guidance/ index.jsp?action=byID&o=11006
52. NICE (2008a) Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults Ref TA 157). Available at: http://www.nice.org.uk/Guidance/TA157/Guidance/pdf.
53. NICE (2008b) Rivaroxaban for the treatment of venous thromboembolism. Available at: http://www.nice.org.uk/guidance/index.jsp?action=byID&o=12026
54. O'Donnell, M., Linkins, L.A., Kearon Julian, C.J. Hirsh, J. (2003) Reduction of out-of hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroscopy: a systematic review. Archives of Internal Medicine, 163, 1362 1366.
55. Parry, M., Wylde, V. Blom, A.W. (2008) Ninety-day mortality after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent. Journal of Bone and Joint Surgery (British Volume), 90, 306 307.
56. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet, 335, 1295 1302.
57. Roderick, P., Ferris, G., Wilson Halls, K.H., Jackson, D., Collins, R. Baigent, C. (2005) Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anitcoagualtion, dextran and regional anaesthesia as thromboprophylaxis. Health Technology Assessment, 9, 49.
58. Rosendaal, F.R., Van Hylckama Vlieg, A. Doggen, C.J.M. (2007) Venous thrombosis in the elderly. Journal of Thrombosis and Haemostasis, 5 (Suppl. 1 310 317.
59. Rosenthal, D., Wellons, E., Levitt, A.B., Shuler, F.W., O' Conner, R.E. Henderson, V.J. (2004) Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma. Journal of Vascular Surgery, 40, 958 964.
60. Samama, M.M., Cohen, A., Darmon, J.Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.G., Turpie, A.G. Weisslinger, N. (1999) A comparison of enoxeparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxeparin Study Group. New England Journal of Medicine, 341, 793 800.
61. Sanford, M. Plosker, G.L. (2008) Dabigatran etexilate. Drugs, 68, 1699 1709.
62. Schellong, S.M., Beyer, J., Kakkar, A.K., Halbritter, K., Eriksson, B.I., Turpie, A.G., Misselwitz, F. Kalebo, P. (2007) Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. Journal of Thrombosis and Haemostasis, 5, 1431 1437.
63. Sherman, D.G., Albers, G.W., Vladin, C., Fieschi, C., Gabbai, A.A., Kase, C.S., O'Riordan, W. Pineo, G.F., on behalf of the PREVAIL Investigators (2007) The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke: an open-label randomised comparison. Lancet, 369, 1347 1355.
64. Shojania, K.G., Duncan, B.W. McDonald, K.M. (2001). Making Healthcare Safer: A Critical Analysis of Patient Safety Practices. Evidence Report/Technology Assessment No. 43 (Prepared by the University of California at San Franscisco-Stanford. Evidence-Based Practice Centre Under Contract No. 290 97-0013). Agency for Healthcare Research & Quality, Rockville, MD, pp. 332 346.
65. Spencer, F.A., Lessard, D., Emery, C., Reed, G. Goldberg, R.J. (2007) Venous thromboembolism in the outpatient setting. Archives of Internal Medicine, 167, 1471 1475.
66. Spinal Cord Injury Thromboprophylaxis Investigators (2003) Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. Journal of Trauma, 54, 1116 1126.
67. Stein, P.D., Hull, R.D. Pineo, G. (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest, 108, 978 981.
68. Turpie, A.G., Bauer, K.A., Eriksson, B.I. Lassen, M.R. (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthpaedic surgery: a meta-analysis of 4 randomized double-blind studies. Archives of Internal Medicine, 162, 1833 1840.
69. Virchow, R. (1859) Die Cellular Pathologies. Verlag von August Hirschwald, Berlin.
70. Warwick, D., Dahl, O.E. Fisher, W.D. (2008) Orthopaedic thromboprophylaxis: limitations od current guidelines. Journal of Bone and Joint Surgery (British Volume), 90, 127 132.
71. Weitz, J.I. (2006) Emerging anticoagulants for the treatment of venous thromboembolism. Thrombosis and Haemostasis, 96, 274 284.
72. West, J., Perrin, K., Aldington, S., Weatherall, M. Beasley, R. (2008) A case-control study of seated immobility at work as a risk factor for venous thromboembolism. Journal of the Royal Society of Medicine, 101, 237 243.
73. White, R.H. (2003) The epidemiology of venous thromboembolism. Circulation, 107, 1 4.